Literature DB >> 24327463

Bias correction of risk estimates in vaccine safety studies with rare adverse events using a self-controlled case series design.

Chan Zeng, Sophia R Newcomer, Jason M Glanz, Jo Ann Shoup, Matthew F Daley, Simon J Hambidge, Stanley Xu.   

Abstract

The self-controlled case series (SCCS) method is often used to examine the temporal association between vaccination and adverse events using only data from patients who experienced such events. Conditional Poisson regression models are used to estimate incidence rate ratios, and these models perform well with large or medium-sized case samples. However, in some vaccine safety studies, the adverse events studied are rare and the maximum likelihood estimates may be biased. Several bias correction methods have been examined in case-control studies using conditional logistic regression, but none of these methods have been evaluated in studies using the SCCS design. In this study, we used simulations to evaluate 2 bias correction approaches-the Firth penalized maximum likelihood method and Cordeiro and McCullagh's bias reduction after maximum likelihood estimation-with small sample sizes in studies using the SCCS design. The simulations showed that the bias under the SCCS design with a small number of cases can be large and is also sensitive to a short risk period. The Firth correction method provides finite and less biased estimates than the maximum likelihood method and Cordeiro and McCullagh's method. However, limitations still exist when the risk period in the SCCS design is short relative to the entire observation period.

Entities:  

Keywords:  bias correction; penalized maximum likelihood; rare events; self-controlled case series; simulation study; vaccine safety

Mesh:

Substances:

Year:  2013        PMID: 24327463     DOI: 10.1093/aje/kwt211

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  2 in total

1.  The case-crossover design via penalized regression.

Authors:  Sam Doerken; Maja Mockenhaupt; Luigi Naldi; Martin Schumacher; Peggy Sekula
Journal:  BMC Med Res Methodol       Date:  2016-08-22       Impact factor: 4.615

2.  Application of FLIC model to predict adverse events onset in neuroendocrine tumors treated with PRRT.

Authors:  F Scalorbi; G Argiroffi; M Baccini; L Gherardini; V Fuoco; N Prinzi; S Pusceddu; E M Garanzini; G Centonze; M Kirienko; E Seregni; M Milione; M Maccauro
Journal:  Sci Rep       Date:  2021-09-30       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.